alanine has been researched along with anandamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bisogno, T; Burstein, S; Chang, SY; Coop, A; De Petrocellis, L; Di Marzo, V; Huang, SM; Maeda, DY; Petros, TJ; Sivakumar, R; Walker, JM; Zavitsanos, PA; Zipkin, RE | 1 |
Galadari, S; Jaligam, V; Oz, M; Petroianu, G; Shippenberg, TS; Shuba, YM | 1 |
2 other study(ies) available for alanine and anandamide
Article | Year |
---|---|
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain.
Topics: Alanine; Amidohydrolases; Amino Acids; Animals; Arachidonic Acid; Arachidonic Acids; Brain; Calcium; Cattle; Dose-Response Relationship, Drug; Endocannabinoids; Formaldehyde; gamma-Aminobutyric Acid; Gas Chromatography-Mass Spectrometry; Glycine; Kinetics; Models, Chemical; Pain; Polyunsaturated Alkamides; Protein Binding; Rats; Signal Transduction; Time Factors; Tissue Distribution | 2001 |
The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.
Topics: Alanine; Arachidonic Acids; Benzamides; Calcium; Cannabinoid Receptor Modulators; Carbamates; Cell Line, Transformed; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Humans; Luminescent Proteins; Microscopy, Confocal; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Scavenger; Silicone Elastomers; Time Factors; Transfection; Tritium; Tropanes | 2010 |